Literature DB >> 23857176

Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locus.

Alok V Joglekar1, Roger P Hollis, Gabriela Kuftinec, Shantha Senadheera, Rebecca Chan, Donald B Kohn.   

Abstract

We investigated the use of integrase-defective lentiviral vectors (IDLVs) for transient delivery of zinc finger nucleases (ZFNs) and donor templates for site-specific modification of the human adenosine deaminase (hADA) gene. Initially, we constructed IDLVs carrying ZFN monomers (Single-IDLVs) and found them to be able to deliver their gene-editing payload to K562 cells successfully upon cotransduction, with minimal cytotoxicity. To simplify delivery, we designed an IDLV construct to deliver both ZFN monomers from the same vector (Double-IDLV). However, this construct in its original state was prone to rearrangements of the vector genome, resulting in greatly reduced functionality; this was due to recombination between highly similar ZFN monomers arranged in tandem. We modified the Double-IDLV constructs to reduce recombination and restored simultaneous delivery of both ZFNs. We also tested an IDLV construct for delivery of donor templates and demonstrated its efficacy for gene modification. In summary, we highlighted the importance of modifying vector design for co-delivery of highly similar sequences inherent to genome-editing nucleases, and demonstrated significant improvement in the use of IDLVs for delivery of ZFNs and donor templates for genome modification.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23857176      PMCID: PMC3776625          DOI: 10.1038/mt.2013.106

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  35 in total

1.  Developing novel lentiviral vectors into clinical products.

Authors:  Anna Leath; Kenneth Cornetta
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

2.  A rapid and general assay for monitoring endogenous gene modification.

Authors:  Dmitry Y Guschin; Adam J Waite; George E Katibah; Jeffrey C Miller; Michael C Holmes; Edward J Rebar
Journal:  Methods Mol Biol       Date:  2010

Review 3.  The AAV vector toolkit: poised at the clinical crossroads.

Authors:  Aravind Asokan; David V Schaffer; R Jude Samulski
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

4.  Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells.

Authors:  Laetitia P L Pelascini; Josephine M Janssen; Manuel A F V Gonçalves
Journal:  Hum Gene Ther       Date:  2012-12-11       Impact factor: 5.695

5.  Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer.

Authors:  Elena Provasi; Pietro Genovese; Angelo Lombardo; Zulma Magnani; Pei-Qi Liu; Andreas Reik; Victoria Chu; David E Paschon; Lei Zhang; Jurgen Kuball; Barbara Camisa; Attilio Bondanza; Giulia Casorati; Maurilio Ponzoni; Fabio Ciceri; Claudio Bordignon; Philip D Greenberg; Michael C Holmes; Philip D Gregory; Luigi Naldini; Chiara Bonini
Journal:  Nat Med       Date:  2012-05       Impact factor: 53.440

Review 6.  The discovery of zinc fingers and their applications in gene regulation and genome manipulation.

Authors:  Aaron Klug
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

Review 7.  Progress and prospects: zinc-finger nucleases as gene therapy agents.

Authors:  D Carroll
Journal:  Gene Ther       Date:  2008-09-11       Impact factor: 5.250

8.  Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.

Authors:  Elena E Perez; Jianbin Wang; Jeffrey C Miller; Yann Jouvenot; Kenneth A Kim; Olga Liu; Nathaniel Wang; Gary Lee; Victor V Bartsevich; Ya-Li Lee; Dmitry Y Guschin; Igor Rupniewski; Adam J Waite; Carmine Carpenito; Richard G Carroll; Jordan S Orange; Fyodor D Urnov; Edward J Rebar; Dale Ando; Philip D Gregory; James L Riley; Michael C Holmes; Carl H June
Journal:  Nat Biotechnol       Date:  2008-06-29       Impact factor: 54.908

9.  Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.

Authors:  Nathalie Cartier; Salima Hacein-Bey-Abina; Cynthia C Bartholomae; Gabor Veres; Manfred Schmidt; Ina Kutschera; Michel Vidaud; Ulrich Abel; Liliane Dal-Cortivo; Laure Caccavelli; Nizar Mahlaoui; Véronique Kiermer; Denice Mittelstaedt; Céline Bellesme; Najiba Lahlou; François Lefrère; Stéphane Blanche; Muriel Audit; Emmanuel Payen; Philippe Leboulch; Bruno l'Homme; Pierre Bougnères; Christof Von Kalle; Alain Fischer; Marina Cavazzana-Calvo; Patrick Aubourg
Journal:  Science       Date:  2009-11-06       Impact factor: 47.728

10.  Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases.

Authors:  Dirk Hockemeyer; Frank Soldner; Caroline Beard; Qing Gao; Maisam Mitalipova; Russell C DeKelver; George E Katibah; Ranier Amora; Elizabeth A Boydston; Bryan Zeitler; Xiangdong Meng; Jeffrey C Miller; Lei Zhang; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Rudolf Jaenisch
Journal:  Nat Biotechnol       Date:  2009-08-13       Impact factor: 54.908

View more
  35 in total

1.  Genome editing in human stem cells.

Authors:  Susan M Byrne; Prashant Mali; George M Church
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

2.  Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells.

Authors:  Jia Liu; Thomas Gaj; Yifeng Yang; Nan Wang; Sailan Shui; Sojung Kim; Chidananda Nagamangala Kanchiswamy; Jin-Soo Kim; Carlos F Barbas
Journal:  Nat Protoc       Date:  2015-10-22       Impact factor: 13.491

3.  Dissecting the mechanism of histone deacetylase inhibitors to enhance the activity of zinc finger nucleases delivered by integrase-defective lentiviral vectors.

Authors:  Alok V Joglekar; Libby Stein; Michelle Ho; Megan D Hoban; Roger P Hollis; Donald B Kohn
Journal:  Hum Gene Ther       Date:  2014-04-02       Impact factor: 5.695

Review 4.  Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect.

Authors:  Yu-Fan Chuang; Andrew J Phipps; Fan-Li Lin; Valerie Hecht; Alex W Hewitt; Peng-Yuan Wang; Guei-Sheung Liu
Journal:  Cell Mol Life Sci       Date:  2021-01-03       Impact factor: 9.261

5.  Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome.

Authors:  Caroline Y Kuo; Joseph D Long; Beatriz Campo-Fernandez; Satiro de Oliveira; Aaron R Cooper; Zulema Romero; Megan D Hoban; Alok V Joglekar; Georgia R Lill; Michael L Kaufman; Sorel Fitz-Gibbon; Xiaoyan Wang; Roger P Hollis; Donald B Kohn
Journal:  Cell Rep       Date:  2018-05-29       Impact factor: 9.423

Review 6.  A genome editing primer for the hematologist.

Authors:  Megan D Hoban; Daniel E Bauer
Journal:  Blood       Date:  2016-04-06       Impact factor: 22.113

Review 7.  Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles.

Authors:  Kyung-Rok Yu; Hannah Natanson; Cynthia E Dunbar
Journal:  Hum Gene Ther       Date:  2016-08-02       Impact factor: 5.695

Review 8.  New frontiers in the therapy of primary immunodeficiency: From gene addition to gene editing.

Authors:  Donald B Kohn; Caroline Y Kuo
Journal:  J Allergy Clin Immunol       Date:  2017-03       Impact factor: 10.793

9.  Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells.

Authors:  Joseph Long; Megan D Hoban; Aaron R Cooper; Michael L Kaufman; Caroline Y Kuo; Beatriz Campo-Fernandez; Dianne Lumaquin; Roger P Hollis; Xiaoyan Wang; Donald B Kohn; Zulema Romero
Journal:  Mol Ther       Date:  2017-11-09       Impact factor: 11.454

10.  Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.

Authors:  Megan D Hoban; Gregory J Cost; Matthew C Mendel; Zulema Romero; Michael L Kaufman; Alok V Joglekar; Michelle Ho; Dianne Lumaquin; David Gray; Georgia R Lill; Aaron R Cooper; Fabrizia Urbinati; Shantha Senadheera; Allen Zhu; Pei-Qi Liu; David E Paschon; Lei Zhang; Edward J Rebar; Andrew Wilber; Xiaoyan Wang; Philip D Gregory; Michael C Holmes; Andreas Reik; Roger P Hollis; Donald B Kohn
Journal:  Blood       Date:  2015-03-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.